Akari Therapeutics is an oncology biotechnology company developing next-generation antibody drug conjugates (ADCs) with a unique payload, PH1, which targets RNA splicing. Utilizing its innovative ADC ...

HyperLight Corporation ("HyperLight"), creator of the TFLN Chiplet(TM) Platform, today announced the availability of 400G-per-lane thin-film lithium niobate (TFLN) photonic integrated circuits (PICs) ...

Researchers have identified a mechanism by which acetylcholine, a neurotransmitter best known for its role in muscle control and attention, can effectively commandeer serotonin release inside the ...

Livestock breeders could soon have more tools to improve the health and quality of their animals, thanks to a recent study ...

A team of astronomers at the University of Washington has identified what appears to be the aftermath of two planets smashing into each other around a star roughly 11,000 light-years from Earth. The ...

The light did not fade the way it was supposed to. After blazing into view about a billion light-years from Earth, the ...

This newly FDA-approved system offers a groundbreaking device for adults with RA. VENTURA, Calif., March 11, 2026 /PRNewswire/ -- With nearly 1.5 million Americans suffering from rheumatoid arthritis ...

OpenLight to Showcase Production Capabilities for AI, Cloud, and High Speed Networking at OFC 2026 SANTA CLARA, CA, ...

Targeted modulation of certain intracellular signaling proteins could represent an exciting new approach to drug development.

Measuring high aspect ratio and composite micro-trenches without damage is critical for advanced microfabrication, yet conventional coherence scanning interferometry often suffers from a low signal-to ...

Particle therapy experts gathered in London to discuss the transformative potential of laser-driven proton and ion beams ...